Detalhe da pesquisa
1.
Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.
J Pathol
; 249(3): 343-355, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257576
2.
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.
Gut
; 66(7): 1286-1296, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27849562
3.
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors.
Invest New Drugs
; 34(5): 654-62, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230034
4.
Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms.
Endocr Relat Cancer
; 31(6)2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642579
5.
Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas.
Neuroendocrinology
; 97(4): 331-40, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343749
6.
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment.
Cancers (Basel)
; 15(14)2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509366
7.
Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene Loss.
JCO Precis Oncol
; 6: e2200129, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001861
8.
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells.
Mol Cancer Ther
; 17(1): 60-72, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051320
9.
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.
Oncotarget
; 8(13): 20974-20987, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423496
10.
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.
Cancer Cell
; 30(3): 485-498, 2016 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27523909
11.
The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.
Oncotarget
; 6(34): 36731-45, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26447612
12.
Mechanisms of local invasion in enteroendocrine tumors: identification of novel candidate cytoskeleton-associated proteins in an experimental mouse model by a proteomic approach and validation in human tumors.
Mol Cell Endocrinol
; 399: 154-63, 2015 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25224486
13.
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.
Cancer Cell
; 30(3): 501-503, 2016 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622340